Corpay CFO granted stock and options awards

Walker Peter reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Walker Peter reported acquisition or exercise transactions in this Form 4 filing.

Corpay, Inc. Chief Financial Officer Peter Walker reported equity awards on February 24, 2026. He received 11,467 Employee Stock Options and a grant of 1,772 shares of Common Stock, both at a stated price of $0.00 per share as compensation.

The restricted stock will vest in three equal installments of 33% on February 24, 2027, 2028 and 2029, if he remains employed on each vesting date. The options will vest 25% per year on February 24, 2027, 2028, 2029 and 2030, also conditioned on continued employment.

Insider Trade Summary

Grant/Award: 13,239 shares

Grant/Award 2 txns

Insider Walker Peter

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Options	11,467	$0.00	$0.00
Grant/Award	Common Stock	1,772	$0.00	$0.00

Holdings After Transaction: Employee Stock Options — 11,467 contracts (Direct); Common Stock — 6,696 shares (Direct)

Footnotes (2)

1. F1. Restricted stock that will vest ratably (33%) on February 24, 2027, 2028 and 2029, subject to the Reporting Person's continued employment on the applicable vesting dates.
2. F2. Options vest ratably (25%) on February 24, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued employment on the applicable vesting dates.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Corpay (CPAY) CFO Peter Walker report in this Form 4?

Corpay CFO Peter Walker reported equity compensation awards on February 24, 2026. He received 11,467 employee stock options and 1,772 shares of common stock, both granted at a stated price of $0.00 per share as part of his compensation package.

How many stock options did the Corpay (CPAY) CFO receive?

Peter Walker received 11,467 employee stock options on February 24, 2026. These options vest in four equal 25% installments on February 24 of 2027, 2028, 2029 and 2030, subject to his continued employment on each applicable vesting date.

How many Corpay (CPAY) common shares were granted to the CFO?

The CFO was granted 1,772 shares of Corpay common stock as restricted stock. These shares vest in three equal 33% installments on February 24, 2027, 2028 and 2029, provided he remains employed on each of those vesting dates.

Are the Corpay (CPAY) CFO’s new equity awards immediately vested?

No, the awards are not immediately vested. The 1,772 restricted shares vest 33% annually from 2027 to 2029, while the 11,467 stock options vest 25% annually from 2027 through 2030, all conditioned on continued employment at each vesting date.

What are the vesting terms for the Corpay (CPAY) CFO’s restricted stock?

The restricted stock vests ratably at 33% on February 24, 2027, 2028 and 2029. Each vesting installment requires that the reporting person, Peter Walker, remains employed with Corpay on the applicable vesting date, as specified in the Form 4 footnote.

What are the vesting terms for the Corpay (CPAY) CFO’s stock options?

The options vest ratably at 25% on February 24, 2027, 2028, 2029 and 2030. Vesting depends on Peter Walker’s continued employment with Corpay on each vesting date, according to the detailed vesting schedule disclosed in the Form 4 footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 09:14 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walker Peter

(Last) (First) (Middle)

3280 PEACHTREE RD NE

SUITE 2400

(Street)

ATLANTA GA 30305

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CORPAY, INC. [ CPAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	02/24/2026		A		1,772	A	$0	6,696	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options(2)	$338.77	02/24/2026		A		11,467		02/24/2027	02/24/2036	Common Stock	11,467	$0	11,467	D

Explanation of Responses:

1. Restricted stock that will vest ratably (33%) on February 24, 2027, 2028 and 2029, subject to the Reporting Person's continued employment on the applicable vesting dates.

2. Options vest ratably (25%) on February 24, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued employment on the applicable vesting dates.

	/s/ Crystal Williams, under a power of attorney	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.